Show simple item record

dc.contributor.authorMezzomo, Lisiane Cervieript_BR
dc.contributor.authorSpalding, Silvia Mariapt_BR
dc.contributor.authorLimberger, Renata Pereirapt_BR
dc.contributor.authorCalil, Luciane Noalpt_BR
dc.contributor.authorMezzari, Adelinapt_BR
dc.date.accessioned2020-08-04T03:38:35Zpt_BR
dc.date.issued2020pt_BR
dc.identifier.issn2230-7605pt_BR
dc.identifier.urihttp://hdl.handle.net/10183/212573pt_BR
dc.description.abstractHereditary mutations of genes involved in DNA repair have resulted in increased susceptibility to a variety of cancers. Mutations in ataxia telangiectasia mutated (ATM) gene result in an autossomal recessive disorder ataxia telangiectasia syndrome (AT), which manifests with greater predisposition to various types of cancer, radiotherapy resistance and adverse prognosis. Therefore, patients with AT and their cells are radiosensitive, mainly because ATM protein kinase is a regulator of DNA damage identification and cell cycle control in response to ionizing radiation. Blood relatives of AT can also carry a pathogenic ATM mutation, which presents similar or even other risks (not yet completely described), although apparently healthy. Due to the unusual phenotype of radiosensitive cells in ATM patients, it has been the focus of numerous studies in the past two decades. The efficiency of radiotherapy treatment among ATM patients has been questioned due to its toxic effect on normal tissue. As certain ATM signaling provided valuable information about the response to DNA damage and cancer, but the understanding of the role of ATM in radio sensitivity is still incipient and, therefore, the molecular determinants of the clinical response are poorly understood so far. On the face of these considerations, this work presents a review of the normal structure and function of the ATM with compilation of the current literature on the risk of radio sensitivity and malignancy among patients with mutations in the ATM.en
dc.format.mimetypeapplication/pdfpt_BR
dc.language.isoengpt_BR
dc.relation.ispartofInternational journal of pharmacy and biological sciences. Índia. Vol. 10, n. 2 (Apr. 2020), p. 229-237pt_BR
dc.rightsOpen Accessen
dc.subjectFarmáciapt_BR
dc.subjectAtaxia telangiectasia mutateden
dc.subjectATMen
dc.subjectAtaxia telangiectasiapt_BR
dc.subjectDNA damageen
dc.subjectDano ao DNApt_BR
dc.subjectDNA repairen
dc.subjectReparo do DNApt_BR
dc.subjectRadiation therapyen
dc.subjectRadioterapiapt_BR
dc.subjectCell cycle checkpointen
dc.subjectPontos de checagem do ciclo celularpt_BR
dc.subjectCâncerpt_BR
dc.titleATM Mutations and radio-sensitivity : a review of molecular pathology and cancer susceptibilitypt_BR
dc.typeArtigo de periódicopt_BR
dc.identifier.nrb001115098pt_BR
dc.type.originEstrangeiropt_BR


Files in this item

Thumbnail
   

This item is licensed under a Creative Commons License

Show simple item record